For the latest updates on Gilead’s ongoing response to COVID-19, please click here.

Investor Relations

Contact Us

KiteKonnect®

Newsroom

Recent Press Releases

June 23, 2021
Kite Joint Venture - Fosun Kite - Gains the First CAR T-cell Therapy Approval in China
June 17, 2021
Kite and Shoreline Biosciences Enter Into Strategic Partnership to Develop Novel Allogeneic Cell Therapies

Recent Company Statements

February 9, 2021
Kite Announces U.S. FDA Clearance of Investigational New Drug Application for KITE-222, an Anti-CLL-1 CAR T-Cell Therapy Candidate for Acute Myeloid Leukemia

Explore More

Media Inquiries

Gilead Newsroom